The histidine decarboxylase (HDC) gene complex, [Hdc], comprises the structural gene for mouse kidney HDC and closely linked regulatory elements which determine enzyme concentration and its response to hormones. One of these regulatory elements, Hdc-e, determines the response (induction or repression) of kidney HDC to oestrogen. HDC is oestrogen-inducible in C57BL/10 and oestrogen-repressible in DBA/2 and C57BL/6; alleles of Hdc-e segregate in crosses between C57BL/1O and DBA/2 and between the C57BL substrains. Two different haplotypes of 
Introduction
The concentration of histidine decarboxylase (HDC; E.C. 4.1.1.22) in mouse kidney is under multihormonal control. In C57BL/10 mice HDC is inducible by thyroxine and oestrogen (and pregnancy) and is repressible by androgens (Rosengren, 1962; Kahlson & Rosengren, 1968; Henningsson & Rosengren, 1972; Grahn et al. 1973; Schayer & Reilly, 1975; Bulfield & Nahum, 1978) . Variation in the response of HDC to hormones has been discovered amongst strains of mice (Martin, 1983; Martin & Bulfield, 1984a ; R. J. Middleton and S. A. M. Martin, unpublished) , as well as variation in the endogenous levels of the enzyme and its structure (Martin & Bulfield, 1984A; Martin et al. 1984) . Analysis of the different phenotypes at the biochemical, genetical and molecular levels will reveal the various mechanisms by which HDC activity and concentration are regulated.
A gene complex, [Hdc] , comprising a single structural gene and regulatory elements has been identified and mapped to chromosome 2 (Martin & Bulfield, 1984a, b; Martin et al. 1984) and other unlinked genes are also known to affect HDC expression (S. A. M. Martin and R. J. Middleton, unpublished ). Variation in response to oestrogen is widely distributed amongst the inbred strains. Some show oestrogen-induction and others oestrogen-repression of HDC (Martin & Bulfield, 1984a) .
We report that alleles of Hdc-e differ between the substrainsC57BL/10andC57BL/6;HDCisoestrogeninducible in the kidneys of C57BL/10 females and oestrogen-repressible in C57BL/6. Therefore C57BL/6 represents a third, different [Hdc] haplotype . This is only the third reported genetic difference between the C57BL substrains, and the first one known to affect a regulatory function.
Materials and Methods

(i) Animals and hormone treatment
The inbred strains of mice C57BL/1 OScSn (abbreviated to C57BL/10) and C57BL/6 were obtained from Bantin and Kingman Ltd, Grimston, Hull, U.K. and bred ¥ l -¥ z prior to use. The C57BL/Fa strain is maintained in the Department of Genetics, Edinburgh University. Females were used at 2-3 months of age. Mice were implanted with pellets of 17/?-oestradiol for 14 days as described previously (Martin & Bulfield, 1984 a) .
(ii) Histidine decarboxylase assay HDC activity was assayed by the release of Martin and G. Bulfield (Martin et al. 1984) . Enzyme activity is expressed as nmols histidine utilized/min/g wet weight kidney tissue at 30 °C.
(iii) Immunoprecipitation HDC concentration was titrated in kidney homogenates by immunoprecipitation with an anti-foetal rat HDC antiserum (the gift of Dr T. Watanabe, Osaka University School of Medicine, Japan). Kidneys were homogenized in 5 x v/w of 0 1 M potassium phosphate buffer, pH 6-8,001 % sodium azide, at 4 °C and the homogenates were centrifuged at 1000 g av for 15 min. Increasing volumes of the supernatants were incubated with constant volumes of the antiserum in a total volume of 215 fi\ for 1 h at room temperature and then overnight at 4 °C. Ten /A of protein A (S. aureuscells; Sigma) in phosphate buffer was added and incubation continued at room temperature for 30 min with gentle shaking. The mixtures were centrifuged for 5 min in an Eppendorf minifuge to precipitate the S. aureus cells with the antigen-antibody complexes, and 200 /i\ of supernatant was assayed for residual HDC activity as described. The data was analysed by statistical regression analysis using a semi-log plot (Martin & Bulfield, 1984a) , and the volume of antiserum required to precipitate 50% of the initial HDC activity was calculated.
Results
(i) Effect of oestrogen on levels of histidine decarboxylase activity in the C51BL substrains
Females of the substrains C57BL/10 and C57BL/6 have the same low HDC activity phenotype (Martin et al. 1984) , but can be distinguished by their response to administered oestrogen. Whereas HDC is oestrogeninducible in the kidneys of C57BL/10 animals, it is oestrogen-repressible in C57BL/6 (Table 1) . As reported previously (Martin & Bulfield, 1984a) , the magnitude of HDC induction and repression is not large but the changes in enzyme activity due to oestrogen are highly significant (Table 1 ).
The C57BL substrains were separated in the Jackson Laboratory prior to 1937 (Festing, 1979) though some years earlier some of the progenitor stock had been imported into Britain by Gruneberg. The line was passed to Falconer and is still maintained in this laboratory (C57BL/Fa). C57BL/Fa females have the same phenotype as C57BL/6 in the response of HDC to oestrogen. .
(ii) Immunoprecipitation of induced and repressed histidine decarboxylase Induction or repression of HDC levels in response to oestrogen could be due to changes either in specific activity or changes in enzyme concentration. An antifoetal rat antiserum (Fukui, Watanabe & Wada, 1981) which crossreacts with mouse kidney HDC (Martin et al. 1984 ) was used to titrate the changes in HDC concentration due to oestrogen.
In C57BL/10 HDC activity is induced in response to oestrogen, and a correspondingly larger volume of the antiserum was required to precipitate 50% of the enzyme activity (Table 2) . Conversely a proportionally smaller volume of antiserum precipitated 50% of the repressed enzyme activity in C57BL/6 homogenates. For both strains then, the ratio (oestrogentreated/control) HDC activity was very close to the ratio of amount of antiserum required to inhibit the enzyme to 50% of its initial activity. Therefore induction of enzyme activity in C57BL/10 and its repression in C57BL/6 are consistent with changes in HDC concentration, due to altered rates of enzyme synthesis or degradation.
(iii) Segregation analysis Both C57BL substrains have low HDC activity but they differ in their response to oestrogen. HDC activity in the kidneys of oestrogen-treated (C57BL/10xC57BL/6) F x females is slightly higher than the control levels (Table 1) ; a large number of heterozygotes were scored and the difference was significant. The result is consistent with an additive mode of inheritance of the different responses to oestrogen: the observed HDC activity in oestrogentreated heterozygotes (0-66 nmol/min/g) is not significantly different from the amount expected for additive inheritance (0-59 nmol/min/g; x 2 = 0-0083, N.S.; Table 1 ).
Codominant monogenic inheritance is confirmed by the distribution of phenotypes observed in progeny from a backcross of the F x to C57BL/10 (Fig. 1) . HDC activities in oestrogen-treated F x animals are intermediate between those of the parental strains. Back- , and Hdc-s b which determine the concentration of HDC in mouse kidneys and properties affected by the enzyme's structure respectively (Martin et al. 1984; Martin & Bulfield, 19846) .
Discussion
A locus, Hdc-e, determines the response (induction or repression) of HDC to administered oestrogen. The effect of oestrogen on HDC activity is specific to kidney tissue. Immunoprecipitation with a specific anti-HDC antibody has shown that induction and repression of enzyme activity correspond to changes in HDC concentration and therefore to changes in the rate of enzyme synthesis or degradation. Hdc-e is linked to the HDC structural gene on chromosome 2 (Martin & Bulfield, 1984a, b) ; together these and other loci (Martin et al. 1984; R. J. Middleton and S. A. M. Martin, unpublished) comprise the HDC gene complex, [Hdc] .
Two alleles of Hdc-e have been identified; both are widely distributed amongst the inbred strains. HDC is oestrogen-inducible in the kidneys of C57BL/10 mice and 6 other strains (Hdc-e b ) and oestrogen-repressible in C57BL/6, C57BL/Fa, DBA/2 and 5 other strains (Hdc-e*; Martin & Bulfield, 1984a) . This is only the third genetic difference between C57BL/10 and C57BL/6 to have been discovered since the strains were separated around 1937 (Festing, 1979) . The other allelic differences are in Lv (affecting delta-aminolevulinate dehydratase activity; Hutton & Coleman, 1969) and H-9 (histocompatability locus, Graff, Polinsky & Snell, 1971) .
Other than response to oestrogen, no difference between the C57BL substrains in HDC phenotype has Martin & Bulfield, 1984a; this paper. been discovered, in HDC enzyme structure or in the regulation of its activity and concentration, either temporally or in response to the various hormone effectors. The B.IO and B.6 haplotypes are distinguished only by the allelic difference at Hdc-e (Table 3 ). In mammals, genetic analyses of tightly linked genes and gene complexes can be limited by the availability of mixed or recombinant haplotypes (see Pfister et al. 1982) , though recombinants have been discovered in one case (Breen, Lusis & Paigen, 1977) . Therefore it is important that Hdc-e alleles vary independently of the other components of [Hdc] , and this in turn implies that Hdc-e might be an independent component of the gene complex. In the mouse fine structure mapping is limited, largely by breeding practicalities, to obtaining recombination between elements more than about 0-1 CM apart, or about 200 kilobases of DNA apart. Therefore analysis at the genetical level cannot reveal the details of the molecular organization of the HDC gene complex.
Variation within [Hdc] is less likely to be due to recombination than to new mutation of Hdc-e since the geneological relatedness of the strains do not correlate with Hdc-e allele (Table 3, Festing, 1979; Martin & Bulfield, 1984 a) . The phenotype of C57BL/Fa implies that a mutation occurred in C57BL/10. The genetic relatedness of the C57BL substrains and the lack of any other difference in HDC phenotype means that the variant Hdc-e allele is essentially congenic on the C57BL background. This is especially important for the analysis of the gene complex at the molecular level, to identify the specific DNA sequence encoding Hdc-e and to determine the mechanism of its regulation of the structural gene's expression.
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